p53 is a crucial anti-cancer gene [8]; however, research indicates that the mutation frequency of the p53 gene in malignancies is not excessively high (approximately 50%) [9], and in one study, it has shown that p53 overexpression was present in about 42% of ESCC patients [10, 11]. The gene discussed is TP53; the disease is cancer.